Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-111.64%
operating margin TTM
-124.46%
revenue TTM
189.14 Million
revenue per share TTM
1.03$
valuation ratios | |
|---|---|
| pe ratio | -19.02 |
| peg ratio | -1.13 |
| price to book ratio | 18.62 |
| price to sales ratio | 23.17 |
| enterprise value multiple | -21.71 |
| price fair value | 18.62 |
profitability ratios | |
|---|---|
| gross profit margin | 96.01% |
| operating profit margin | -124.46% |
| pretax profit margin | -111.64% |
| net profit margin | -111.64% |
| return on assets | -50.52% |
| return on equity | -75.61% |
| return on capital employed | -87.44% |
liquidity ratios | |
|---|---|
| current ratio | 2.51 |
| quick ratio | 2.51 |
| cash ratio | 2.28 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 33.42 |
| days of payables outstanding | 1,213.04 |
| cash conversion cycle | -1,179.62 |
| receivables turnover | 10.92 |
| payables turnover | 0.30 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | 0.16 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.14 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -9.98 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.18 |
| cash per share | 1.17 |
| operating cash flow per share | -1.18 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -9.98 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -245.17 |
Frequently Asked Questions
When was the last time Wave Life Sciences Ltd. (NASDAQ:WVE) reported earnings?
Wave Life Sciences Ltd. (WVE) published its most recent earnings results on 10-11-2025.
What is Wave Life Sciences Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Wave Life Sciences Ltd. (NASDAQ:WVE)'s trailing twelve months ROE is -75.61%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Wave Life Sciences Ltd. (WVE) currently has a ROA of -50.52%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did WVE's net profit margin stand at?
WVE reported a profit margin of -111.64% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is WVE's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.51 in the most recent quarter. The quick ratio stood at 2.51, with a Debt/Eq ratio of 0.16.